A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
Nammi Therapeutics Inc
Revolution Medicines, Inc.
Turning Point Therapeutics, Inc.
Verastem, Inc.
AstraZeneca
Replimune Inc.
Carevive Systems, Inc.
Revolution Medicines, Inc.
DualityBio Inc.
Lumicell, Inc.
Hoffmann-La Roche
Varian, a Siemens Healthineers Company
I-Mab Biopharma US Limited
Shanghai Juncell Therapeutics
BicycleTx Limited
Revolution Medicines, Inc.
Bolt Biotherapeutics, Inc.
Revolution Medicines, Inc.
Second Life Therapeutics
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Tempus AI
Revolution Medicines, Inc.
Celldex Therapeutics
Hoffmann-La Roche
Shanghai Yunying Medical Technology
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Silverback Therapeutics
Mirror Biologics, Inc.
Auron Healthcare GmbH
Mirror Biologics, Inc.
Poniard Pharmaceuticals
Poniard Pharmaceuticals
Pharmacyclics LLC.
FeRx